2023-02-26-世界卫生组织-COVID-19_Vaccine_Delivery_Partnership_-_January_2023_20页_4mb

Summary of COVID-19 Vaccine Delivery Partnership Situation Report (December 2022 - January 2023)

Global Progress

• Total vaccine doses administered: 13.2 billion globally by January 2023, with 100 million in the 92 Advance Market Commitment (AMC) countries.
• Primary series coverage increased to 65% globally, rising from 47% in January 2022. In AMC countries, coverage doubled from 28% to 53%.
• Booster dose uptake lower, with 31% of the global population receiving at least one booster, but significant gaps: only 2% in low-income countries (LICs) vs. 48% in high-income countries (HICs); healthcare workers: 5.5% in LICs vs. 15% in HICs; older adults: <1% in LICs vs. 93.5% in HICs.
• Global cases surged in December 2022 due to China's relaxation of COVID-19 policies, highest monthly case count since the pandemic began.

Country-Specific Highlights

• Concerted Support Countries (CCS): Average primary coverage increased from 3% in January 2022 to 25% by January 2023. Countries like Chad, Ethiopia, and Somalia showed progress (e.g., Chad at 22.1%, Ethiopia at 32.4%). Three CCS countries (Sierra Leone, Somalia, Zambia) met national targets.
• High-Priority Groups: Coverage for healthcare workers and older adults remains low, with 51% and 49% respectively in CCS countries.
• Chad snapshot: Primary series coverage improved to 24% for its southern campaign, with ongoing support and community engagement.

Last-Mile Delivery Innovations

• Success through mobile teams, community health workers (CHWs), drones, and improved logistics (e.g., Rwanda's drone deliveries, Malawi's solar fridges reduced transport time and cost).
• CHWs played a key role in outreach, but infrastructure challenges (e.g., poor roads, insecurity) persist, leading to inequities.

Transition and Future

• CoVDP will gradually shift core functions to partner agencies by 2023, focusing on integrating COVID-19 vaccines into primary health care and strengthening routine immunization.
• Challenges remain in sustaining uptake, data management, and reaching underserved populations.
• Upcoming events focus on lessons learned, equity, and pandemic preparedness.

Key Findings

• Inequities persist, with LICs lagging in both primary and booster doses.
• Innovations in delivery improved access but need maintenance for long-term impact.
• Global case rise underscores the need for continued vigilance despite vaccination progress.